Are you thinking of deploying Process Analytical Technologies (PAT) and Quality by Design (QbD) strategies for Pharma 4.0?
Reducing time to market is undoubtedly a crucial competitive factor for pharmaceutical companies.
That is why, thanks to our expertise in Process Analytical Technology (PAT) and SIPAT technology, we can help make quality an integral part of your production process, giving you greater flexibility when bringing new products to market.
Right-first-time production through Quality by Design (QbD)
The US Food and Drug Administration (FDA) initiative “Pharmaceutical CGMPs for the 21st Century” has led to a rethink across the pharmaceutical industry. Quality by Design (QbD), which moves quality controls that previously took place after manufacturing into the process itself, aims to accelerate processes and prevent the production of defective batches of medicines. The introduction of Process Analytical Technology (PAT) supports a right-first-time production process that delivers the correct product quality immediately.
Send us an email at info@oytec.es or use the form below and we will schedule a video call with our specialists..
Latest News
Fast & Furious eBR Implementation
YES, that's right, a Fast & Furious eBR Implementation is possible. It is no longer a utopia to carry out an Electronic Batch Record implementation in a fast and massive way for any manufacturing plant. Regardless of the manufacturing area: bulk, weighing, or...
EMA and FDA: The 10 Principles of Pharmaceutical AI
The European Union and the United States published the Guiding Principles for Good AI Practices in Drug Development on January 14, 2026, as part of a strategic effort to harmonize regulatory criteria. The EMA-FDA collaborative work initiative has the mission of...
The FDA and Pharmaceutical AI: Key Points from the 2025 Draft on Model Credibility
The FDA positions credibility as an indispensable condition for utilising AI in pharmaceutical regulatory decision-making, within a risk-proportionate framework that demands traceability, transparency and validation throughout the entire model lifecycle. This approach...
